Building Quality, Regulatory Convergence and a Shared Future for Biotherapies
Translational medicine converts laboratory discoveries into safe, effective and accessible clinical practice, becoming the defining infrastructure of contemporary science. It plays a central role in bringing advances in genomics, cell and gene therapy, regenerative medicine and advanced biotherapies to patients who need them.
Around the world, research is accelerating the path from bench to bedside, compressing timelines that once spanned decades into years, transforming hematology-oncology, transfusion medicine and cellular therapies as some of the most dynamic frontiers in medicine.
Advanced therapy medicinal products (ATMPs), CAR-T, other cell-based immunotherapies and next-generation biologics are now embedded in oncology, hematology and regenerative programs worldwide. International organizations such as AABB, the International Society for Cell & Gene Therapy and the European Society for Blood and Marrow Transplantation continue to refine the standards governing the procurement, manufacturing, safety and clinical use of these therapies.
By Claudio Darío Dufour, MD, and Maria De Los Angeles Muñiz, MD, AABB Spanish Language Subsection, Contributing Writers
August 2026
View Issue
PREVIOUS STORY
New Biotherapies Supplement From TransfusionBACK TO ISSUE
August 2026
Transfusion is AABB’s scholarly, peer-reviewed monthly journal, publishing the latest on technological advances, clinical research and controversial issues related to transfusion medicine, blood banking, biotherapies and tissue transplantation. Access of Transfusion is free to all AABB members.
Learn More About Transfusion Journal
Keep abreast of what's happening in the field of biotherapies with CellSource - AABB's monthly update on the latest biotherapies news.
To submit news about the blood and biotherapies field to AABB, please email news@aabb.org.
President
Jose Cancelas, MD, PhD, CABP
Chief Executive Officer
Debra Ben Avram, FASAE, CAE
Chief Communications and Engagement Officer
Julia Zimmerman
Director of Marketing and Communications
Jay Lewis, MPH
Managing Editor
Kendra Y. Mims, MFA
Senior Communications Manager
Drew Case
AABB News
(ISSN 1523939X) is published monthly, except for the combined November/December issue for the members of AABB; 4550 Montgomery Avenue; Suite 700 North Tower; Bethesda, MD 20814.
AABB is an international, not-for-profit association representing individuals and institutions involved in transfusion medicine, cellular therapies and patient blood management. The association is committed to improving health by developing and delivering standards, accreditation and educational programs that focus on optimizing patient and donor care and safety.
+1.301.907.6977
Email: news@aabb.org
Website: www.aabb.org
Copyright 2025 by AABB.
Views and opinions expressed in AABB News are not necessarily endorsed by AABB unless expressly stated.
Notice to Copiers: Reproduction in whole or part is strictly prohibited unless written permission has been granted by the publisher. AABB members need not obtain prior permission if proper credit is given.
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977
